HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
YI
111, Inc.
There isn't enough reported data to score YI yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
YI Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
YI's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
YI PE Valuation
YI has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
YI Forward outlook
There aren't enough analyst estimates for YI to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
YI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.79 | -$0.51 |
| Q1 2026 | -$1.46 | -$0.27 |
| Q4 2025 | -$1.14 | -$0.01 |
| Q3 2025 | -$1.21 | +$3.29 |
| Q2 2025 | -$1.28 | +$4.58 |
| Q1 2025 | -$1.19 | +$5.45 |
| Q4 2024 | -$1.13 | +$5.84 |
| Q3 2024 | -$4.50 | +$0.68 |
YI has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over YI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
YI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $345.2M | -28% |
| Q1 2026 | $354.4M | -33% |
| Q4 2025 | $417.4M | -28% |
| Q3 2025 | $450.3M | -17% |
| Q2 2025 | $481.1M | -6.4% |
| Q1 2025 | $529.6M | 0% |
| Q4 2024 | $577.4M | -6.3% |
| Q3 2024 | $540.4M | -1.8% |
YI's revenue has slid since its 2022 peak: $345M last quarter, down 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1% | -1 points |
| Q1 2026 | -0.8% | -0.8 points |
| Q4 2025 | -0.2% | 0 points |
| Q3 2025 | -0.1% | -0.2 points |
| Q2 2025 | 0% | -0.1 points |
| Q1 2025 | 0% | -0.1 points |
| Q4 2024 | -0.2% | +4.8 points |
| Q3 2024 | 0.1% | +2.3 points |
YI has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over YI on cash generation, producing positive trailing cash flow while its opponent burns cash.
YI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.7M | +$7.5M |
| Q1 2026 | -$13.8M | -181% |
| Q4 2025 | $3.8M | +$13.4M |
| Q3 2025 | $5.7M | -65% |
| Q2 2025 | -$9.2M | -166% |
| Q1 2025 | $16.9M | +3.8% |
| Q4 2024 | -$9.6M | +$21.5M |
| Q3 2024 | $16.5M | +212% |
YI has burned cash in most quarters: −$6M over the past year, against $15M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over YI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
YI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +28.3K shares |
| 1 year | +1.7% | +145K shares |
| 3 years | +5% | +418K shares |
| 5 years | +6.4% | +533K shares |
| Available history | +7.5% | +615K shares |
YI has 9M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $2M |
| Q3 2024 | — |
YI hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
YI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -22.3x | Net Cash |
| Q3 2025 | -14.5x | Net Cash |
| Q2 2025 | -14.1x | Net Cash |
| Q1 2025 | -14.0x | Net Cash |
| Q4 2024 | -8.4x | Net Cash |
YI has the edge over HIMS on leverage, with a lower net debt burden relative to earnings.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
YI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.5 | Oversold |
| Stochastic | 13.2 | Oversold |
YI's weekly RSI is 28 (oversold) and its Stochastic is 13 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
YI PE vs Healthcare Sector
YI has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
YI has stronger trend alignment. HIMS is above 0 of 5 weekly averages versus YI above 0 of 4.
YI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.07 | 7.2% below |
| 20 week MA | $3.47 | 18% below |
| 50 week MA | $4.79 | 41% below |
| 100 week MA | $5.76 | 51% below |
YI is in a downtrend: it's below all four of its weekly moving averages, and 51% below its 100-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
YI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $11.6 | $7.35 | -36% |
| 2025 | $7.35 | $3.08 | -58% |
| 2026 YTD | $3.08 | $2.85 | -7.5% |
YI has the edge over HIMS on returns for 2026, with the stronger performance.